LOS ANGELES — Use of intra-articular platelet-rich plasma significantly improved pain and function in patients with osteoarthritis at 6 months and may be a superior alternative to hyaluronic acid, according to study findings presented at the Arthroscopy Association of North America Annual Meeting.
“Our study suggests that lower-leukocyte [platelet-rich plasma] is… effective in the treatment of knee osteoarthritis, with superior and meaningful clinical differences in favor of [platelet-rich plasma] over [hyaluronic acid] at 6 months and 12 months,” Annemarie Tilton, BBA, said during her presentation.
Tilton and colleagues randomly assigned 99 patients with a minimum of 3 months of symptomatic unilateral knee osteoarthritis (OA) and Kellgren Lawrence grade 1-3 OA to receive 3 weekly injections of either platelet-rich plasma (PRP) or hyaluronic acid (HA). Patients completed Lysholm, IKDC, WOMAC and VAS pain surveys and underwent clinical examination at 6 weeks, 12 weeks and 24 weeks after index treatment. During each treatment visit and at 3-month and 6-month follow-up, patients also underwent ultrasound-guided knee aspiration for synovial fluid analysis.
The Brian Cole MD Knee Guide and Shoulder Guide are your own personalized injury APP's for your pocket. These APP's provide users with detailed information, treatment and identification of the most common injuries.